anmelden
OMX Stockholm 30
3.099,50
PKT
+38,01
PKT
+1,24
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Stockholm 30-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 18.07.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 18.07.12 | Ericsson (Telefon L.M.Ericsson) (B) buy | Sarasin Research | |
| 18.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 18.07.12 | Alfa Laval underperform | Exane-BNP Paribas SA | |
| 18.07.12 | AstraZeneca reduce | Nomura | |
| 17.07.12 | Ericsson (Telefon L.M.Ericsson) (B) outperform | Cheuvreux SA | |
| 17.07.12 | ABB (Asea Brown Boveri) outperform | Sanford C. Bernstein and Co., Inc. | |
| 16.07.12 | AstraZeneca buy | UBS AG | |
| 16.07.12 | ABB (Asea Brown Boveri) buy | Citigroup Corp. | |
| 16.07.12 | Swedbank underperform | Cheuvreux SA | |
| 13.07.12 | Ericsson (Telefon L.M.Ericsson) (B) overweight | Morgan Stanley | |
| 13.07.12 | Ericsson (Telefon L.M.Ericsson) (B) sell | Société Générale Group S.A. (SG) | |
| 12.07.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 12.07.12 | Ericsson (Telefon L.M.Ericsson) (B) outperform | Exane-BNP Paribas SA | |
| 11.07.12 | Telia outperform | Exane-BNP Paribas SA | |
| 10.07.12 | Volvo (B) overweight | J.P. Morgan Cazenove | |
| 10.07.12 | Alfa Laval buy | UBS AG | |
| 10.07.12 | Telia hold | Deutsche Bank AG | |
| 09.07.12 | Volvo (B) buy | UBS AG | |
| 09.07.12 | SKF Group (B, Fria) buy | Société Générale Group S.A. (SG) | |
| 09.07.12 | Volvo (B) hold | Société Générale Group S.A. (SG) | |
| 09.07.12 | Sandvik sell | Société Générale Group S.A. (SG) | |
| 06.07.12 | Ericsson (Telefon L.M.Ericsson) (B) hold | Deutsche Bank AG | |
| 06.07.12 | Ericsson (Telefon L.M.Ericsson) (B) overweight | J.P. Morgan Cazenove | |
| 03.07.12 | AstraZeneca underperform | Credit Suisse Group | |
| 03.07.12 | AstraZeneca neutral | Banc of America Securities-Merrill Lynch | |
| 03.07.12 | Sandvik neutral | Nomura | |
| 03.07.12 | AstraZeneca buy | UBS AG | |
| 03.07.12 | AstraZeneca reduce | Nomura | |
| 02.07.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 02.07.12 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
| 02.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 02.07.12 | Swedbank hold | Société Générale Group S.A. (SG) | |
| 28.06.12 | AstraZeneca hold | Deutsche Bank AG | |
| 28.06.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 28.06.12 | Skandinaviska Enskilda Banken (SEB) reduce | Nomura | |
| 27.06.12 | Swedbank buy | Nomura | |
| 26.06.12 | ABB (Asea Brown Boveri) neutral | Exane-BNP Paribas SA | |
| 25.06.12 | Volvo (B) neutral | Goldman Sachs Group Inc. | |
| 22.06.12 | Hennes Mauritz (H M, H&M) overweight | HSBC |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.